Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Burcon NutraScience Corp T.BU

Alternate Symbol(s):  BRCNF

Burcon NutraScience Corporation is a Canada-based technology company. The Company is engaged in the development of plant-based proteins for foods and beverages. The Company has a patent portfolio covering its specialty plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The Company is involved in the production, sales, marketing and... see more

TSX:BU - Post Discussion

Burcon NutraScience Corp > Merit: “We anticipate to grow to four times the size.”
View:
Post by fundmanager1944 on Jan 28, 2022 3:56pm

Merit: “We anticipate to grow to four times the size.”

https://www.linkedin.com/feed/update/urn:li:activity:6892913171909222400/
Comment by capitalraiser on Jan 31, 2022 4:26pm
today could indicate the start of this
Comment by Summer001 on Feb 01, 2022 3:28am
... anticipate to grow....? Burcon has been making assumptions for 20 years without results. Moreover, even a quadrupling of production capacity would only justify the current price level. The problem with Burcons technology is that the production costs are too high and the production quality is not stable enough. The advantages of the technology do not outweigh the disadvantages to the ...more  
Comment by ParamaYogananda on Feb 01, 2022 7:14am
Not Burcon speaks of a quadrupling, but Merit. How do you justify the reviews of Tesla, Apple, Biontech etc.?
Comment by Summer001 on Feb 01, 2022 8:03am
´How do you justify the reviews of Tesla, Apple, Biontech?´  Turnover, profit and growth! How do you justify a market cap of CA$130 million for Burcon? Zero, zero, zero, since more than 20 years...and now a fired CEO, which was probably the most positive news in a long time. But even that certainly does not mean anything positive in the short term.
Comment by groundskeeper on Feb 01, 2022 1:48pm
Summer.  In large part I agree with your opinions on the current state of Burcon.   The markets are clearly indicating this is a $130 million company based on current information.  (~$30m for their stake in Merit, $10m in cash, and $80 -- $100m for the IP).   Kappel has to lead the Feb 14 Investor's Call.   Putting a lame duck CEO out front on that call will be ...more  
Comment by Trendsetter on Feb 01, 2022 4:24pm
Groundskeeper for once a decent thought provoking post instead of the unintersting and negative Capitalraiser (aka fundmanager and Summer...does he own shares or not?)   Regardless, I appreciate you thoughts but have a few comments and questions of you to add.  I doubt the Q3 results will  be showing much in the way of revenue as its my understanding Merit were still trying ...more  
Comment by fundmanager1944 on Feb 10, 2022 11:22am
perhaps sales show how urgent this might be up again with more volume as usual (in the last weeks)
Comment by fundmanager1944 on Feb 10, 2022 11:46am
ONETHIRTYSEVEN
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities